Legal Controls of Psychoactive Substances in Europe

Living reference work entry
Part of the Springer Reference Psychologie book series (SRP)


The more powerful psychoactive substances have been controlled due to the harms they cause to public health. Those that were found in certain regions of the world have been controlled by international treaties, limiting their use to medical and scientific purposes. The treaties also established a system to carefully assess the benefits and harms of new substances and control them accordingly; control is then enforced by criminal penalties at national level. This established system is now under pressure due to globalisation and the internet, with two new substances found in Europe every week, and countries look for new ways to control substances quickly without the need to prove a public health threat. In some countries, “psychoactive” moves towards becoming a synonym for “harmful”; in others, supply of low-risk substances for non-medical use is now permitted.


Drug Narcotic Psychoactive Law European 


  1. Anderson, P., & Baumberg, B. (2006). Alcohol in Europe – A public health perspective. London: Institute of Alcohol Studies.Google Scholar
  2. Ballotta, D., Bergeron, H., & Hughes, B. (2008). Cannabis control in Europe. In EMCDDA (Ed.), A cannabis reader: Global issues and local experiences (Monograph series 8, Vol. 1, pp. 97–116). Lisbon: EMCDDA.Google Scholar
  3. Danenberg, E., Sorge, L., Wieniawski, W., Elliott, S., Amato, L., & Scholten, W. (2013). Modernizing methodology for the WHO assessment of substances for the international drug control conventions. Drug and Alcohol Dependence, 131, 175–181.CrossRefPubMedGoogle Scholar
  4. EMCDDA. (2009). Risk assessment of new psychoactive substances operating guidelines. Lisbon: EMCDDA.Google Scholar
  5. EMCDDA. (2015). Perspectives on drugs; Legal approaches to controlling new psychoactive substances. Retrieved 2015, from EMCDDA:
  6. European Commission. (2009). On the implementation of Framework Decision 2004/757/JHA laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking [SEC(2009)1661]. Google Scholar
  7. European Commission. (2013). Proposal for a regulation of the European parliament and of the council on new psychoactive substances COM(2013) 619. European Commission.Google Scholar
  8. European Court of Justice. (2014). Joined cases C-358/13 and C 181/14: Judgment of the court (Fourth chamber) of 10 July 2014. European Union.Google Scholar
  9. Evans-Brown, M., Gallegos, A., Francis, W., Christie, R., Cunningham, A., Sekula, J., et al. (2015). New psychoactive substances in Europe; An update from the EU Early Warning System. Lisbon: EMCDDA.Google Scholar
  10. Hughes, B. (2015). Alternatives to punishment for drug using offenders. Lisbon: EMCDDA.Google Scholar
  11. Hughes, B., & Blidaru, T. (2009). Legal responses to new psychoactive substances in Europe. Lisbon: EMCDDA.Google Scholar
  12. Hughes, B., & Evans-Brown, M. (2015). New psychoactive substances in Europe: Innovative legal responses. Lisbon: EMCDDA.Google Scholar
  13. Hughes, B., & Griffiths, P. (2014). Regulatory approaches to new psychoactive substances (NPS) in the European Union. Addiction, 109, 1591–1593.CrossRefPubMedGoogle Scholar
  14. Hughes, B., & Winstock, A. (2012). Controlling new drugs under marketing regulations. Addiction, 107, 1894–1899.CrossRefPubMedGoogle Scholar
  15. Thomson Reuters Aranzadi. (2013). Study on criminal sanction legislation and practice in representative Member States – Final Report. European Commission.Google Scholar

Authors and Affiliations

  1. 1.EMCDDALisbonPortugal

Personalised recommendations